Literature DB >> 29666097

Natural history of luminal A breast invasive ductal carcinoma in an elderly.

Geok Hoon Lim1,2, Samantha Piao Xue Tay1, Mihir Gudi3.   

Abstract

An elderly woman, with no clinically palpable breast lump, presented with an initially benign-appearing lesion on ultrasound. She was followed up to reveal the natural history of luminal A breast cancer. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  breast cancer; breast surgery; radiology

Mesh：

Year:  2018        PMID： 29666097      PMCID： PMC5905775          DOI： 10.1136/bcr-2018-224218

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  15 in total

1.  Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

Authors:  Peter C Dubsky; Raimund Jakesz; Brigitte Mlineritsch; Sabine Pöstlberger; Hellmut Samonigg; Werner Kwasny; Christoph Tausch; Herbert Stöger; Karin Haider; Florian Fitzal; Christian F Singer; Michael Stierer; Paul Sevelda; Gero Luschin-Ebengreuth; Susanne Taucher; Margaretha Rudas; Rupert Bartsch; Günther G Steger; Richard Greil; Lidija Filipcic; Michael Gnant
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

2.  Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.

Authors:  Vivianne C G Tjan-Heijnen; Irene E G van Hellemond; Petronella G M Peer; Astrid C P Swinkels; Carolien H Smorenburg; Maurice J C van der Sangen; Judith R Kroep; Hiltje De Graaf; Aafke H Honkoop; Frans L G Erdkamp; Franchette W P J van den Berkmortel; Maaike de Boer; Wilfred K de Roos; Sabine C Linn; Alexander L T Imholz; Caroline M Seynaeve
Journal:  Lancet Oncol       Date:  2017-10-12       Impact factor: 41.316

3.  A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.

Authors:  Torsten O Nielsen; Joel S Parker; Samuel Leung; David Voduc; Mark Ebbert; Tammi Vickery; Sherri R Davies; Jacqueline Snider; Inge J Stijleman; Jerry Reed; Maggie C U Cheang; Elaine R Mardis; Charles M Perou; Philip S Bernard; Matthew J Ellis
Journal:  Clin Cancer Res       Date:  2010-09-13       Impact factor: 12.531

4.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

5.  Age-related breast diagnosis.

Authors:  E E Sterns
Journal:  Can J Surg       Date:  1992-02       Impact factor: 2.089

6.  The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival.

Authors:  Ines Vasconcelos; Afsana Hussainzada; Stefan Berger; Ellen Fietze; Jörg Linke; Friederike Siedentopf; Winfried Schoenegg
Journal:  Breast       Date:  2016-08-18       Impact factor: 4.380

7.  Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts.

Authors:  Eun Young Chae; Hak Hee Kim; Joo Hee Cha; Hee Jung Shin; Hyunji Kim
Journal:  J Ultrasound Med       Date:  2013-09       Impact factor: 2.153

8.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

Authors:  Jack Cuzick; Ivana Sestak; Michael Baum; Aman Buzdar; Anthony Howell; Mitch Dowsett; John F Forbes
Journal:  Lancet Oncol       Date:  2010-11-17       Impact factor: 41.316

Review 9.  Specific Aspects of Breast Cancer Therapy of Elderly Women.

Authors:  Petra Tesarova
Journal:  Biomed Res Int       Date:  2016-10-11       Impact factor: 3.411

10.  MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.

Authors:  Kirsi Holli-Helenius; Annukka Salminen; Irina Rinta-Kiikka; Ilkka Koskivuo; Nina Brück; Pia Boström; Riitta Parkkola
Journal:  BMC Med Imaging       Date:  2017-12-29       Impact factor: 1.930
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.